Medical Journals

P85 Regulatory Subunit of Pi3k Mediates Camp-pka and Estrogens Biological Effects on Growth and Survival.

Authors:
  • Cosentino C
  • Di Domenico M
  • Porcellini A
  • Cuozzo C
  • De Gregorio G
  • Santillo M R
  • Agnese S
  • Di Stasio R
  • Feliciello A
  • Migliaccio A
  • Avvedimento E V

From: Dipartimento di Biologia e Patologia Molecolare e Cellulare, Istituto di Endocrinologia ed Oncologia Sperimentale del CNR, Università Federico II, Napoli, Italy.

Oncogene

  • Publish Date: Mar 2007
  • ISSN: 0950-9232
  • Volume: 26
  • Issue: 14
  • Pages: 2095-103
  • Medium: Print
  • Language: English
  • Citation (JAMA): Cosentino C, Di Domenico M, Porcellini A, et al. P85 Regulatory Subunit of Pi3k Mediates Camp-pka and Estrogens Biological Effects on Growth and Survival.. Oncogene Mar 2007;26:2095-103

Abstract

Cyclic adenosine 3’5’ monophosphate (cAMP) and protein kinase A (PKA) cooperate with phosphatidylinositol 3’ kinase (PI3K) signals in the control of growth and survival. To determine the molecular mechanism(s) involved, we identified and mutagenized a specific serine (residue 83) in p85alpha(PI3K), which is phosphorylated in vivo and in vitro by PKA. Expression of p85alpha(PI3K) mutants (alanine or aspartic substitutions) significantly altered the biological responses of the cells to cAMP. cAMP protection from anoikis was reduced in cells expressing the alanine version p85alpha(PI3K). These cells did not arrest in G1 in the presence of cAMP, whereas cells expressing the aspartic mutant p85D accumulated in G1 even in the absence of cAMP. S phase was still efficiently inhibited by cAMP in cells expressing both mutants. The binding of PI3K to Ras p21 was greatly reduced in cells expressing p85A in the presence or absence of cAMP. Conversely, expression of the aspartic mutant stimulated robustly the binding of PI3K to p21 Ras in the presence of cAMP. Mutation in the Ser 83 inhibited cAMP, but not PDGF stimulation of PI3K. Conversely, the p85D aspartic mutant amplified cAMP stimulation of PI3K activity. Phosphorylation of Ser 83 by cAMP-PKA in p85alpha(PI3K) was also necessary for estrogen signaling as expression of p85A or p85D mutants inhibited or amplified, respectively, the binding of estrogen receptor to p85alpha and AKT phosphorylation induced by estrogens. The data presented indicate that: (1) phosphorylation of Ser 83 in p85alpha(PI3K) is critical for cAMP-PKA induced G1 arrest and survival in mouse 3T3 fibroblasts; (2) this site is necessary for amplification of estrogen signals by cAMP-PKA and related receptors. Finally, these data suggest a general mechanism of PI3K regulation by cAMP, operating in various cell types and under different conditions.

Mesh Headings (Keywords): 1-Phosphatidylinositol 3-Kinase, Animals, Cell Proliferation, Cell Survival, Cells, Cultured, Cyclic AMP, Cyclic AMP-Dependent Protein Kinases, Cytoprotection, Estrogens, G1 Phase, Humans, Mutation, Phosphorylation, Platelet-Derived Growth Factor, Proto-Oncogene Proteins p21(ras), Serine, Signal Transduction


Check for Full Text / PubMed Unique Identifier (PMID): 17016431


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.